Emerging Edge
@emergingedge.bsky.social
4 followers 0 following 48 posts
Distributing News, Delivering Intelligence.
Posts Media Videos Starter Packs
Poolbeg is entering a catalyst-rich phase. POLB-001 is in Phase 2a with 2026 data due, while its oral GLP-1 obesity drug offers a second major shot. With £10m cash and funding into 2027, Poolbeg could be well-positioned for growth.

#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
Greatland Gold’s latest quarterly update: strong production, record cash generation, and costs tracking toward the low end of guidance. We cover all the key numbers investors need to know from the September-2025 quarter.

#GGP #Gold #MiningStocks #Mining #SmallCapStocks #Investing #StockMarketNews
ECR Minerals - Investors should watch for Raglan due diligence, Blue Mountain assays, Creswick JV progress, and Bailieston exploration updates.

#ECR #Gold $Gold #CriticalMinerals #Antimony #RareEarths #MiningStocks #Investing
Poolbeg’s planned merger with Hookipa collapsed in early 2025, sending shares lower. The company rebounded with funding, partnerships, and a Phase 2a trial launch, showing resilience in a volatile small-cap sector.

#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
Greatland Resources 100% ownership of Telfer and Havieron, a debt-free balance sheet, and clear production guidance for FY26. Learn why investors are watching this dual gold-and-copper producer heading into 2026.

#GGP #Gold #MiningStocks #Mining #SmallCapStocks #Investing #StockMarketNews
ECR Minerals reports it is funded into Q1 2026, supporting ongoing business activities.

#ECR #Gold $Gold #CriticalMinerals #Antimony #RareEarths #MiningStocks #Investing
United Oil & Gas faces typical junior explorer risks in funding, timing, and partner deals. Catalysts include Jamaica’s geochem programme, farm-out progress, and UK redevelopment planning.

#UOG #EnergyIndustry #Energystocks #Investing #StockMarket #Trading #StocksToWatch
Poolbeg expanded POLB-001 patent coverage to South Korea in 2025, adding to rights in the U.S., Europe, and China. Combined with Orphan Drug status, Poolbeg now has strong IP protection in key global markets.

#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
ECR Minerals holds around A$75 million in carried-forward tax losses in Australia. These can offset future profits, improving project economics by up to A$18–22 million.

#ECR #Gold $Gold #CriticalMinerals #Antimony #RareEarths #MiningStocks #Investing
United Oil & Gas has Jamaica secured until 2028 and Waddock Cross until 2029. With long-dated licences and a lean structure, the company has time and clarity to execute its strategy.

#UOG #EnergyIndustry #Energystocks #Investing #StockMarket #Trading #StocksToWatch
Poolbeg’s obesity programme develops an oral GLP-1 drug to rival injectables like Wegovy and Ozempic. With trials planned for late 2025, it could offer a compliance-friendly alternative in a booming global market.

#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
ECR Minerals appointment of Mike Parker as Senior Independent Non-Executive Director adds exploration and governance experience to the board.

#ECR #Gold $Gold #CriticalMinerals #Antimony #RareEarths #MiningStocks #Investing
United Oil & Gas completed its exit from Egypt in October 2024 and settled Rockhopper liabilities in January 2025, removing legacy issues.

#UOG #EnergyIndustry #Energystocks #Investing #StockMarket #Trading #StocksToWatch
Poolbeg’s POLB-001 addresses risks from bispecific antibody therapies. It could become the first preventative CRS treatment, with FDA Orphan Drug exclusivity adding commercial strength in oncology markets.

#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
ECR Minerals holds exploration licences EL006911 and EL006912 in Victoria, covering historic gold mining regions with high-grade potential.

#ECR #Gold $Gold #CriticalMinerals #Antimony #RareEarths #MiningStocks #Investing
Poolbeg’s POLB-001 targets the p38 MAP kinase pathway to control cytokines like IL-6 and TNF-alpha, aiming to prevent immune storms while preserving cancer therapy outcomes. If proven, it could unlock safer immunotherapy use.

#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
ECR Minerals – Creswick will advance through a JV with Bold Gold, which is funding exploration in exchange for staged project ownership.

#ECR #Gold $Gold #CriticalMinerals #Antimony #RareEarths #MiningStocks #Investing
United Oil & Gas holds 26% of the Waddock Cross oil field in Dorset. Studies show around 57 million barrels in place, with redevelopment potential via a horizontal well.

#UOG #EnergyIndustry #Energystocks #Investing #StockMarket #Trading #StocksToWatch
Poolbeg, valued at £26m, is a micro-cap targeting billion-dollar markets in oncology and obesity. Investors view it as high-risk, high-reward, with potential for re-rating on clinical success.

#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
ECR Minerals – Bailieston in Victoria has delivered standout drill results, including high-grade gold and critical mineral antimony.

#ECR #Gold $Gold #CriticalMinerals #Antimony #RareEarths #MiningStocks #Investing
United Oil & Gas reports multiple companies under NDA reviewing the Walton Morant data. With the licence extended and permits granted, the farm-out process is a key near-term catalyst.

#UOG #EnergyIndustry #Energystocks #Investing #StockMarket #Trading #StocksToWatch
Aptamer Group has announced a major £360,000 contract with a top 3 global pharma company to develop Optimer® binders for targeted radiopharmaceuticals.

#APTA #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
Poolbeg’s Executive Chair Cathal Friel bought 4m shares at 3p in June 2025, while CEO Jeremy Skillington also holds stock. Former Glen Dimplex CEO Sean O’Driscoll added credibility with a 5.7% stake.

#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
Lolworth adds early-stage gold, lithium, and rare earth exploration to ECR Minerals Queensland portfolio.

#ECR #Gold $Gold #CriticalMinerals #Antimony #RareEarths #MiningStocks #Investing
United Oil & Gas highlights an unrisked NPV10 of about $23 billion at $80 oil, based on 2.4 billion barrels. Risk-adjusted values are lower, but the potential prize is transformational.

#UOG #EnergyIndustry #Energystocks #Investing #StockMarket #Trading #StocksToWatch